Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
This study has been completed.
Sponsor:
Celator Pharmaceuticals
Information provided by (Responsible Party):
Celator Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00788892
First received: November 10, 2008
Last updated: May 16, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2011 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | May 16, 2012 |